Plasma cell infiltration of synovium is common in longstanding rheumatoid arthritis (RA). The mechanism(s) underlying synovial B cell proliferation remains unclear. One theory invokes nonspecific polyclonal stimuli; another implicates antigen as the driving force. Antigen-driven repertoires are characteristically enriched for related sets of V gene segments containing similar sequence in the antigen binding site (complementaritydetermining regions; CDRs). To study the forces shaping B cell proliferation, we analyzed VK transcripts expressed in the synovium of an RA patient. We found Humkv325, a developmentally regulated VKIII gene segment associated with autoantibody reactivity, in > 10% of randomly-chosen synovial CK cDNAs. Two sets of sequences contained identical charged amino acid residues at the VK-JK join, apparently due to N region addition. We generated "signature" oligonucleotides from these CDR3s and probed PCR amplified VK products from the synovium and PBLs of the same patient, and from PBLs and spleen of individuals without rheumatic disease. Significant expression of transcripts containing these unique CDR3 sequences occurred only in the patient's synovium. Thus, in this synovium there is expansion of a limited set of B cell clones expressing antigen receptors that bear evidence of antigen selection. (J. Clin. Invest. 1994. 93:361-370.)
Introduction
RA is an inflammatory disease involving the synovial membrane of diarthrodial joints (1, 2) . Synovial plasma cells are relatively infrequent in the early stages, but increasingly prominent as the disease progresses. Indeed, local immunoglobulin production may reach levels equivalent to spleen (3, 4) . The most common autoantibodies in RA patients, i.e., patients exhibiting positive tests for serum RF, (4) . Local production of RF is thought to participate in the pathogenesis of tissue injury in RA, although the exact mechanism of tissue damage is unclear (2, 5, 6) .
Immunoglobulins are heterodimeric proteins consisting of two heavy and two light chains (7, 8) . Each chain can be divided into a variable domain that defines the antigen specificity of the molecule, and a constant domain that is responsible for effector functions. Variable domains contain three intervals of sequence hypervariability, termed complementarity-determining regions (CDRs),' that are separated from each other by four intervals of relatively constant sequence, termed FRs. In man, K light chain variable domains are assembled by splicing together one of more than 85 variable (V) gene segments (50 potentially functional) to one of five joining (J) gene segments (7, 9) . The VK gene segment encodes CDRs 1 and 2, whereas CDR 3 is the product of VK-JK joining. The heavy and light chain CDRs are juxtaposed in the mature protein and form the antigen binding site (8) .
We utilized a molecular cloning approach in order to examine the antibody repertoire expressed in the diseased synovium of a patient with longstanding, seropositive RA. Although the cloning strategies employed in this work do not permit us to directly correlate antibody sequence with antigen specificity, they have the compensatory advantage of allowing us to randomly sample the light chain repertoire at the site of tissue injury without the introduction of bias due to preferential cell growth under in vitro conditions. Transcript representation in a randomly primed cDNA library reflects mRNA abundance in the original tissue. At the terminal stages of differentiation, plasma cells may express 150-1 000-fold greater immunoglobulin transcript levels per cell than their pre-B cell progenitors (10) . Thus, cDNA library generation and screening enhances our ability to characterize the expression oftranscripts derived from immunoglobulin-secreting cells within this synovium and to determine ifthere are clonal relationships among them.
Initial hybridization analysis of synovial transcripts suggested that the K light chain repertoire might be enriched for transcripts containing the Humkv325 gene segment. The sequence of one of these Humkv325-containing clones, 10S2, has been previously reported (11) . The Humkv325 VK gene segment is ofparticular interest since it is developmentally regulated ( 12) and is frequently expressed in the CD5 + B cell population implicated in lymphoid malignancies ( 1 3, 14) and autoantibody expression (15) . In germline or near-germline form, the Humkv325 gene segment can be found in IgMK paraproteins with RF activity ( 16, 17) , as well as in antibodies with anti-intermediate filament activity ( 18) , anti-single-stranded DNA activity ( 19) , and anti-LDL activity (20) . This association between the Humkv325 gene segment and autoreactivity led us to focus on the Humkv325-containing repertoire within this synovial sample.
In this study, we identified seven additional Humkv325-containing transcripts from a random sampling of40 CK+ synovial transcripts. We found a repertoire of mutated Humkv325-containing light chains that was enriched for highly charged CDR 3 regions. Among these clones were transcripts that had likely arisen from the same B cell progenitor, as well as transcripts that shared identical CDR 3 deduced amino acid sequence yet were derived from different B cell ancestors. Using a PCR-based strategy, we tested the synovium and the peripheral blood of our patient and demonstrated that B cells expressing these K chains were prominent only in the synovium. These findings suggest that the expansion of B cells in this autoimmune disease is likely the product of local antigen receptordriven selection.
Methods
Patient characteristics, tissue isolation and cDNA library preparation. The clinical characteristics of our 62-yr-old female patient, B.C., and the methods used to process involved synovial tissue have been reported previously (11 Individual PCR amplifications were performed on a I-,d aliquot of first strand cDNA from each sample. The efficacy of cDNA preparation was measured by amplification for # actin (26) . Primers for amplifying actin (Actin 1 and 2) and for hybridization (Actin 3) are listed in Table I . PCR conditions were: 25 cycles of denaturation at 940C for 1 min, annealing at 50'C for 2 min, extension at 720C for 4 min, and final extension at 720C for 10 min.
In conjunction with an anti-sense CK oligonucleotide (LSK-19, Table I), VW-containing transcripts were amplified with a degenerate sense oligonucleotide (LSK-40) derived from the leader sequence ofall known VK gene segments (27) (Table I) were end labeled with y[32P]ATP and polynucleotide kinase to a specific activity of 1 X 106 to 5 X 107 cpm/ml of hybridization solution. The filters were hybridized for 12-16 h at 37°C in Southern blot buffer in the presence of 0.5 mg of salmon sperm DNA. Hybridization stringency was determined at the time of washing. Filters were washed twice in SSC-1% SDS at room temperature for 5 min, then overnight at 42°C. Autoradiograms were generated by exposing the filters at -70°C for 30 min to 4 d with intensifying screens. After the initial exposure, the filters were washed again overnight at a temperature 5°C below the calculated melting temperature ofthe oligonucleotide probe (Table I) 
Results
Cloning and identification of seven Humkv325-derived transcriptsfrom synovium. In our previous analysis of24 CK + transcripts cloned from dissociated synovial cells from this patient, we identified a single Humkv325-containing clone, 10S2, among the 15 cDNAs that contained VK sequence ( 1) . Be Table I ). Five additional Humkv325-derived clones were identified and sequenced, making a total ofseven Humkv325-derived clones, in addition to clone 10S2 from the original analysis (Fig. 1) . Their sequences were compared to the known germline VK repertoire (28) (29) (30) and their likely Humkv325 germline origin confirmed by parsimony.
Oligoclonal expansion ofB cells expressing IOS2-like K light chains. The Humkv325 gene segment represents only one of50 potentially functional VK gene segments in the haploid genome, yet Humkv325 was used by at least 12.5% (8 of 64) of this random sampling of synovial K transcripts (P < 0.00004, binomial distribution). Evidence of clonal relatedness was sought by comparing the sequences of these Humkv325-containing cDNAs to each other ( Fig. 1 ). From the leader to the terminus of the JK sequence, two clones, 21 S2 and 38S1, were base for base identical to the Humkv325 clone, 1OS2, that we had previously identified from the first library (11) .
Although derived from different cDNA libraries, the 5' termini of clones 1OS2 and 21S2 are identical. The identity of these sequences did not allow us to definitively distinguish between the presence ofa preferred reverse transcriptase stop site or possible contamination of the second library with lOS2 sequences. However, there is no question that 38S1 is a unique clone because the 5' sequence extends beyond the site of reverse transcriptase termination in the other two (Fig. 2) . Out of a total of64 CK+ cDNA transcripts, three (5%) contained 1OS2-like sequences. Thus, B cells bearing 1OS2-like transcripts are over-represented in the synovium of this patient.
Replacement/silent substitution ratio analysis of the Humkv325-derived sequences. Insight into the forces that have shaped the products of somatic mutation can be gained from analysis of the amino acids specified by the altered codons. Nucleotide changes in a codon may result in either a replacement (R) of the amino acid by another or preservation of the same residue, termed a silent (S) mutation. Codons undergoing random mutation are predicted to yield a replacement/silent substitution (R/S) ratio of2.9 (31, 32) . Selection for conservation ofprotein sequence yields R/S ratios ofless than 2.9, whereas selection for diversity results in ratios significantly greater than 2.9. For example, antibodies elaborated during a secondary response to antigen are associated with R/S ratios in the CDRs significantly greater than 2.9, indicating positive selection for high affinity antigen binding sites (32) (33) (34) . The average R/S ratio in the framework regions of the 8 Humkv325-derived variable domains was 0.8 (FR 1,0.3; FR 2, 0.7; FR 3, 1.1; FR 4, 0.5), indicating preservation of essential function.
Among the eight sequences, there were eight replacement mutations in CDR 2 giving an R/S ratio of 8.0. The R/S ratio for CDR 1 was 3.0 and for CDR 3 was 1.7, yielding an average R/S ratio of only 3.0. Although this pattern initially suggested random mutation in the CDRs, closer inspection revealed numerous shared or conserved amino acid changes among these sequences. For example, six of the eight clones had mutations resulting in changes from serine to asparagine at position 31 and both the lOS2-like sequences ( 1OS2, 21S2, and 38S1) and clone 28S1 contained a threonine at position 29 Analysis ofthe CDR 3 region discloses selectionfor charged amino acids. Of the 24 amino acid changes from germline sequence in the CDR 3 region, two thirds involve the insertion of charged amino acids: histidine, aspartic acid, glutamic acid, and arginine (P < 0.00002, binomial distribution). Among those sequences with N region addition ( I OS2, 21 S2, 38S 1, and 37S4), all contain an arginine at the VK-JK junction, including the 3 with 11 amino acids in CDR 3.
In clone 28S 1, the VK-JK junctional arginine was generated by germline sequence, whereas the remaining charged amino acids appear to be the products ofsomatic mutation. Although clone 28S 1 does not contain N nucleotides, it shares identical CDR 3 amino acid sequence with clone 37S4, including an arginine at the VK-JK junction. Closer inspection ofclone 28S1 reveals further similarity to the IOS2-like sequences. Among the nine replacement mutations in clone IOS2, three of the amino acid substitutions are also present in clone 28S 1: a Ser to Thr substitution at position 29 in CDR 1 and a Ser to Asn at position 31 in CDR 1, as well as the arginine at the VK-JK junction.
1OS2-like sequences are over-expressed in synovium, but not in peripheral blood. The 1OS2-like sequences contain four bases of N nucleotides at the VK-JK junction. The N nucleotides, in conjunction with somatic mutations in the VK CDR 3, create a sequence "signature" that uniquely identifies clones with this VK-JK join. We performed identical PCR amplifications on cDNA from the RA patient's synovium, her PBLs (obtained within 24 h ofjoint arthroplasty), PBLs ofa normal 32-yr-old volunteer, and mononuclear cells derived from the cadaveric spleen of a 49-yr-old male. Ethidium bromide staining revealed roughly equivalent amplification of VK transcripts in all the tissues tested, a finding confirmed by hybridization with internal oligonucleotides (Fig. 3 A and B) . When like VK-JK join was detected only in the synovium of our patient (Fig. 3 D) .
Hybridization analysis ofPCR amplification products reveals enrichment in the synoviumfor a second set ofsequences with charged CDR 3 domains. To determine whether or not 28S1-like sequences were also over-represented in synovium, we generated a signature oligonucleotide probe (LSK-34) from the CDR 3 sequence of clone 28S 1. This probe was hybridized to our PCR amplified VK-transcripts (Fig. 4) . Autoradiography revealed enrichment for 28S1-like sequences in synovium, but not in the patient's peripheral blood nor in our normal controls.
Clone 16S1 was unique among these synovial clones in that it did not contain an arginine residue in either CDR 3 or FR 4. We generated a signature oligonucleotide probe (LSK-33) from the CDR 3 sequence of 16S1 and hybridized it to our PCR amplified VK-transcripts (Fig. 4) . Unlike the two charged CDR 3 domains, the mutated CDR 3 of 16S1 was expressed at relatively low levels in all samples tested.
To test for the presence ofmore commonly reported VK-JK junctions (nine amino acid CDR 3 and no N region addition), we generated an oligonucleotide signature sequence complementary to a nine amino acid germline Humkv325-JK 1 CDR 3 junction (LSK-37). Hybridization of this oligonucleotide to our panel of VK PCR amplified products revealed the presence of VK-JK rearrangements of this type in all tissues tested, although the level of these rearrangements appeared somewhat lower in the tissues of our patient than in our controls. Thus, it appears that VKIII-containing transcripts from this synovial sample, in contrast to those in normal spleen and PBL, are enriched for CDR 3 regions resembling 28S1 as well as 1OS2. to be solvent-exposed and thus potentially capable of interacting directly with antigen. However, the extent of exposure of residue 31 may depend on the structure ofthe CDR 3 region of the VH gene segment. In contrast, amino acid 96, the most somatically variable residue during initial light chain generation, was not solvent-exposed, but rather buried beneath the surface of the antigen binding site. (Table I) . As in Fig. 3 , the smaller size of bands in lane I in degenerate VK and Humkv325 amplifications is due to use of a more 5' CK primer, H-170. (B) Control strip containing clones with different CDR 3 regions (Fig. 1 C) , hybridized with probes LSK-25, LSK-33, and LSK-34, demonstrating specificity of probes. Washing was done at 60°C in SSC-l% SDS. After washing, the filter was exposed to x-ray film with an intensifying screen for 7 d at -70°C.
Discussion
Using a combination of cDNA library ( 1) ) generated novel antigen binding sites while preserving essential structure. The survivors are thus enriched for replacement mutations in the CDR regions. Thus, although the initial repertoire may be highly diverse, the final repertoire can be dominated by a limited population of sequences derived from different progenitor clones that by chance express the preferred canonical antigen binding sites (35) . A similar focusing of the immune response has also been described in murine models of SLE. The anti-DNA associated idiotype that predominates in the late stages is not readily apparent early in the course of the disease. With time and the progression of disease, enhanced specificity for antigen results in selection for heavy chains that bear arginine residues in the CDR 3 domain. Thus, nonclonally related sequences often share similar somatic mutational changes (36, 37) .
The unique sequence of the CDR 3 region of clones IOS2, 21 S2, and 38S1 suggests they are the product of a single gene rearrangement event. These three sequences represent -5% of the 64 CK positive clones identified in the two unrestricted cDNA libraries from this single synovial sample. PCR analysis confirmed the over-representation of clones bearing these rearrangements in this synovial sample. Approximately 1.6 X 106 cells in this synovial sample were able to secrete immunoglobulin in culture ( 1) . Although it is possible that clones IOS2, 21S2, and 38S1 all arose from the same plasma cell, it is more likely that cells expressing this light chain represent an oligoclonally expanded population of B cells. Such an oligoclonal expansion could be due either to neoplastic transformation or to antigen-driven expansion. To distinguish between these possibilities, we examined the PBLs ofthe patient for the presence of this clone. The apparent absence of expression of this clone in her blood lymphocytes, and the lack of evidence of a neoplastic process over a 3-yr follow-up period, suggest that the expansion of this clone is a local event. These results are compatible with the hypothesis that RA can be a polycentric disease in which immune events at local sites of tissue inflammation are autonomously regulated (38) .
In addition to the IOS2-like sequences, this synovial sample also contains evidence of oligoclonal expansion of B cells expressing other Humkv325-derived K light chains. Clone 37S4 shares identical CDR 3 deduced amino acid sequence with clone 28S 1. Clone 28S1 is the product ofa typical germline join while 37S4 contains non-germline-encoded nucleotides at the VK-JK junction, suggesting convergent evolution of the immune response. Clones 28S1 and lOS2 share sequence similarity in the CDR 1 and 2 regions, but the sequences ofthe CDR 3 regions are different, both in number of amino acid residues and in JK usage (Fig. 1) . Thus, there could potentially be several sets ofoligoclonally expanded B cells in this RA synovium. The shared mutations between apparently nonclonally related transcripts lOS2 and 28S1 are similar to findings in murine models of SLE (36, 37) .
The CDR 3 regions of the heavy and light chains form the center of the classically defined antigen binding pocket (39) . Changes in the sequence of the VK-JK junction introduced by both genetic and somatic mechanisms may thus affect antigen binding and specificity. For example, anti-galactan antibodies are enriched for light chains with isoleucine at the VK-JK junction (40) . mAbs raised in A/J mice against the hapten p-azophenylarsonate all contain an arginine at position 96, which is essential for antigen binding (41 ) . Similarly, the specificity of both IgM and IgG anti-DNA antibodies from (NZB x NZW) F1 mice is dependent on arginine in position 96 of the CDR 3 region of the light chain (36) . Similar patterns of dependence on light chain junctional diversity are seen in man. The most common light chain components of human IgG antibodies against Haemophilus influenzae type b polysaccharide contain an invariant arginine at the VK-JK junction (42) . Therefore, expansion ofB cell clones with unusual sequences at the VK-JK junction is often associated with antigen selection.
The potential diversity of VK-JK splice sites is much less than is possible in immunoglobulin heavy chain variable domains. The overwhelming dominance of nine amino acid CDR 3 regions, the absence of N region addition in light chains, and the absence ofdiversity (D) gene segments contribute to this difference. A nine amino acid CDR 3 region predicts only 21 different possible nucleotide sequence products of Humkv325-JK rearrangements, encoding eight different amino acids at position 96, the splice site (Table II) . Among 36 Humkv325 sequences reported in the literature (8, 43, 44) , none share sequence identity with our clones. Four sequences contain an arginine at position 95A or 96 in association with JK1 and one in association with JK2. One clone was from the peripheral blood of a normal individual (43) , one from an IgM-expressing CLL cell line (45) and two from IgMK cryoglobulins with RF activity (8) . Finally, clone HEW (45) , from a CD5+ B cell expressing the 17.109 CRI, contains 10 amino acids in CDR 3 and likely is the product of N region addition. Based upon the analysis in Table II , the arginine in the JK2-containing IgMK cryoglobulin must be the product of either N region addition or somatic mutation. These findings indicate that autoantibodies with specificities found in RA may express arginine at the VK-JK junction, and that this arginine can be the product of somatic events.
N region addition was found in 4 of8 (50%) Humkv325-derived transcripts from this synovial sample, leading to 11 amino acid CDR 3 regions in three clones. N region addition is associated with the activity of the enzyme TdT (46, 47) . TdT activity is only present in B lineage cells before production ofa (48) (49) (50) . In addition, N region addition has been found in a high proportion of VKIII-containing RFs from RA patients (51 ) . Presumably these are situations in which light chain rearrangement has occurred in the presence of TdT activity. Sequence analysis of the light chains of RFs derived from both normal individuals and patients with rheumatologic disorders revealed that two of nine light chains contained 10 and 11 amino acids in the CDR 3 region, respectively (44) . Both these RFs and the transcripts described in this report may derive from unusual progenitor B cells that failed to regulate TdT expression appropriately. We may speculate that such B cells could be more prone to escape other forms of normal regulation and thus be at greater risk for producing potentially deleterious antibodies. Molecular modeling of the 10S2-like and 28S1-like sequences demonstrates that residue 29 in CDR 1 is clearly solvent-exposed, whereas the degree ofexposure ofCDR 1 residue 31 likely depends on the sequence and structure ofthe VH CDR 3. With respect to the non-solvent-exposed CDR 3 residue 96, the four most closely juxtaposed amino acids are heavy chain residues 99 and 105 (VH CDR 3), light chain residue 99 (VK CDR 3), and light chain residue 37 (VK FR2). Residue 96 in the CDR 3 region may thus affect the conformation of the antibody binding site in one of three ways: directly, indirectly through contacts with the CDR 3 of the light and heavy chain, or by internal interactions with the FR 2 core region. Introduction ofa charged residue into this region ofthe CDR 3 domain may thus influence heavy and light chain pairing.
In germline form, the Humkv325 gene segment encodes a CRI that can be detected by the 17.109 mAb (52) . As is typical for patients with RA, the 17.109 CRI could be detected on less than 1% of serum RF, synovial cell-derived RF, or synovial cell-derived total immunoglobulin from this patient ( 11) . However, our random cDNA library analysis demonstrated that -12.5% of the K light chain transcripts were drawn from the Humkv325 germline gene segment. We presume the absence of 17.109 reactivity in the presence ofthe Humkv325 gene may be explained, at least in part, by somatic mutation in the CDR regions that define the epitope. We are currently in the process of expressing these transcripts to test this hypothesis. Our results provide a further caveat for studies that rely exclusively on use of idiotypic antibodies for analysis of the expressed antibody repertoire.
Several biologic questions ofinterest remain unanswered as a result of limitations of cDNA analysis. The antigen specificities of antibodies containing the described clonally related VK gene segments, including potential differences in reactivities of closely related VK gene segments (e.g., 28S1 and 37S4) are unknown, but expression oflight chains in prokaryotic systems may provide useful insights in this regard. The identity of heavy chains paired with these light chains remains unknown. Single-cell PCR, which allows correlation of heavy chains with light chains, may eliminate this problem in future studies.
Antibodies containing light chains with 10S2-like CDR 3 regions were found only in this patient's synovium, but not in other tissues sampled, including the patient's PBLs, and spleen lymphocytes and PBLs from normal individuals. Although unaffected synovial tissue would theoretically provide a better control, normal synovial tissue does not contain B lineage cells.
Analysis of synovial tissue obtained simultaneously from different joints in the same patient could potentially address the question of whether there are tissue-specific or local differences in immunoglobulin gene segment expression. Similar studies of additional patients should provide information regarding inter-individual variation.
In summary, we have provided proof of oligoclonal expansion of B cells expressing the Humkv325 gene segment in the involved synovium of a patient with longstanding RA. The high level of expression of at least one clone suggests that we may be able to identify the companion heavy chain sequence and thus gain insight into the antigen specificity of this antibody. The roles of somatic mutation, variation in the length of the light chain CDR 3 region, and N nucleotide addition in the normal light chain repertoire and the identity of the putative antigen(s) that may have elicited the B cell proliferative response remain major open questions that will be the focus of future investigations.
